Asahi Kasei Bioprocess America, Inc. serves as the primary U.S. subsidiary of Asahi Kasei Bioprocess, operating within the Asahi Kasei Life Science segment of the Japanese multinational Asahi Kasei Corporation. The company develops and supplies specialized bioprocess equipment, consumables, and scientific support services to enhance safety, efficiency, and purity in pharmaceutical and biopharmaceutical manufacturing.
Its portfolio centers on virus removal filters under the Planova™ brand, the industry’s first hollow-fiber virus filters launched in 1989, alongside fluid management systems for inline buffer formulation, chromatography, oligonucleotide synthesis, and process automation. These technologies support production of antibodies, plasma derivatives, oligonucleotides, peptides, and other therapeutics under GMP standards.
Headquartered in Glenview, Illinois, with a training center in Chelmsford, Massachusetts, the company maintains manufacturing and R&D capabilities in the United States. It belongs to a global Asahi Kasei Bioprocess network spanning Japan, Europe, China, and additional regions. Strategic acquisitions, including TechniKrom, Inc. and Bionique Testing Laboratories, have broadened its offerings into CDMO services and biosafety testing.
As a recognized leader in virus filtration and downstream bioprocessing, Asahi Kasei Bioprocess America partners with global biopharma manufacturers to deliver reliable, high-performance solutions that address evolving regulatory and production demands.
Also known as Asahi Kasei Bioprocess, Inc. and Asahi Kasei Bioprocess America.
Automated single‑use benchtop virus filtration for lab‑scale and process development; supports Planova 35N filters and will be shown at BPI East (Booth 606).
